Sign in

CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company

ACHIEVE LIFE SCIENCES, INC.

Sign in to watch
Ticker
ACHV
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
954343413
Phone
425-686-1500
Business address
22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
Former names
ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
  1. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  2. SCHEDULE 13G Stake Statement of Beneficial Ownership
  3. SCHEDULE 13G Stake Statement of Beneficial Ownership
  4. 8-K Event Bylaws or fiscal year change · Shareholder vote results
  5. ARS Other Annual Report to Security Holders
  6. DEF 14A Proxy Proxy Statement
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 8-K Event Executive or director change
  12. PRE 14A Proxy Proxy Statement (Preliminary)
  13. EFFECT Other Notice of Effectiveness
  14. CORRESP Other Correspondence Between Filers and SEC Staff
  15. UPLOAD Other SEC-generated Letter
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. S-8 Other Securities Offered to Employees in Benefit Plans
  19. S-3 Offering Registration Statement
  20. 10-Q Report Quarterly Report

Page 2 of 68 · 1,358 filings